Tositumomab

From Proteopedia

Revision as of 06:38, 6 December 2010 by David Canner (Talk | contribs)
Jump to: navigation, search

Pharmacokinetics

Anti-CD20 Monoclonal Antibody Pharmacokinetics
Parameter Tositumomab Ofatumumab Rituximab Ibritumomab
Tmax (hr) Tositumomab Ofatumumab Rituximab Ibritumomab
Cmax (ng/ml) Tositumomab Ofatumumab Rituximab Ibritumomab
Bioavailability (%) Tositumomab Ofatumumab Rituximab Ibritumomab
Protein Binding (%) Tositumomab Ofatumumab Rituximab Ibritumomab
T1/2 (hr) Tositumomab Ofatumumab Rituximab Ibritumomab
AUC (ng/ml/hr) Tositumomab Ofatumumab Rituximab Ibritumomab
Clearance (L/h) Tositumomab Ofatumumab Rituximab Ibritumomab
IC50 (nM) Tositumomab Ofatumumab Rituximab Ibritumomab
Dosage (mg) Tositumomab Ofatumumab Rituximab Ibritumomab
Metabolism Tositumomab Ofatumumab Rituximab Ibritumomab

Proteopedia Page Contributors and Editors (what is this?)

David Canner

Retrieved from "http://52.214.119.220/wiki/index.php/Tositumomab"
Personal tools